These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7460506)

  • 1. Long-term hemoperfusion with coated activated charcoal.
    Mamdani B; Dunea G; Siemsen AW
    Clin Toxicol; 1980 Nov; 17(4):543-6. PubMed ID: 7460506
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program].
    Mydlík M; Dzúrik R; Derzsiová K; Spustová V
    Cas Lek Cesk; 1983 Dec; 122(51):1573-6. PubMed ID: 6652672
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current concepts of hemoperfusion through activated charcoal in the treatment of internal diseases].
    Dmitriev AA
    Ter Arkh; 1983; 55(6):140-8. PubMed ID: 6351328
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical results of charcoal hemoperfusion: studies of 55 cases extending over 250 incidents].
    Agishi T; Yamashita N; Ota K
    Nihon Rinsho; 1980 Dec; 38(12):4697-702. PubMed ID: 7253246
    [No Abstract]   [Full Text] [Related]  

  • 5. Panel conference. Adsorbent hemoperfusion for blood purification.
    Chang TM; Winchester JF; Rosenbaum J; Saito A; Stefoni S; Shu C; Gurland HL
    Trans Am Soc Artif Intern Organs; 1980; 26():593-7. PubMed ID: 7245556
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of chronic renal insufficiency with hemofiltration with regeneration of the filtrate on adsorbants before re-injection (proceedings)].
    Dequiedt P; Goudaert F; Lelièvre G; Tacquet A
    J Urol Nephrol (Paris); 1979; 85(4-5):334-5. PubMed ID: 480447
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion.
    Rahman MH; Haqqie SS; McGoldrick MD
    Hemodial Int; 2006 Jul; 10(3):256-9. PubMed ID: 16805886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoperfusion for uremia: past, present, and future.
    Winchester JF; Ash SR
    Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activated charcoal surface ultrastructure after haemoperfusion (author's transl)].
    Bucek J; Mydlík M
    Cas Lek Cesk; 1980 Nov; 119(45):1205-7. PubMed ID: 7438181
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemoperfusion: state of the art and future requirements.
    Sideman S; Chang TM
    Artif Organs; 1980 Feb; 4(1):70-5. PubMed ID: 7369897
    [No Abstract]   [Full Text] [Related]  

  • 11. Coated charcoal haemoperfusion.
    Chang TM
    Life Support Syst; 1984; 2(2):99-106. PubMed ID: 6384672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coated activated charcoal hemoperfusion: experience of French anti-poison centers about 60 cases.
    Bismuth C; Conso F; Wattel F; Gosselin B; Lambert H; Genestal M
    Vet Hum Toxicol; 1979; 21 Suppl():2-4. PubMed ID: 505963
    [No Abstract]   [Full Text] [Related]  

  • 13. Basic study of polyetherurethane coated bead-type activated charcoal for direct hemoperfusion.
    Kawanishi H; Nishiki M; Sugiyama M; Cho T; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1983 Mar; 32(1):9-14. PubMed ID: 6863016
    [No Abstract]   [Full Text] [Related]  

  • 14. Digoxin acute intoxication: evaluation of the efficiency of charcoal hemoperfusion.
    Clerckx-Braun F; Kadima N; Lesne M; Mahieu P; Vandenbroucke JM
    Clin Toxicol; 1979; 15(4):437-46. PubMed ID: 540492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hemoperfusion of cross-linked agarose coated activated charcoal (CAAC-II) on T-lymphocyte function in rats and guinea pigs.
    Li F; Shu CD; Li ZM
    Biomater Artif Cells Artif Organs; 1987; 15(1):215-28. PubMed ID: 3502391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of hemosorption in chronic kidney failure].
    Riabov SI; Shostka GD; Lukichev BG; Spiridonov VN; Strelko VV
    Klin Med (Mosk); 1984 Jun; 62(6):50-6. PubMed ID: 6471799
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemofiltration and hemoperfusion performed in series for the purpose of removing beta 2 microglobulin].
    Marangoni R; Civardi F; Savino R; Manfredi A; Masi F; Avanzi C; Lino S
    Cas Lek Cesk; 1989 Sep; 128(39):1217-20. PubMed ID: 2684408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis-related porphyria cutanea tarda--treatment failure with charcoal hemoperfusion.
    McColl KE; Simpson K; Laiwah AY; Thompson GG; McDougall A; Moore MR
    Photodermatol; 1986 Jun; 3(3):169-73. PubMed ID: 3529056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemoperfusion with coated activated charcoal for treating acute poisoning by remedies, plant protectants, and fungi. III. Fungi (author's transl)].
    Okonek S
    Med Klin; 1977 Nov; 72(45):1917-21. PubMed ID: 927297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of hemosorption and hemodialysis in the treatment of chronic renal failure].
    Riabov SI; Shostka GD; Lukichev BG; Strelko VV; Spiridonov VN
    Ter Arkh; 1981; 53(6):15-21. PubMed ID: 7281026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.